Pharmacotherapy: how much drug is there?

Suppr

超能文献

作者信息

Novack Gary D

出版信息

Ocul Surf. 2007 Jan;5(1):58-61. doi: 10.1016/s1542-0124(12)70054-x.

DOI:10.1016/s1542-0124(12)70054-x

PMID:17252167

Abstract

摘要

相似文献

Pharmacotherapy: how much drug is there?

Ocul Surf. 2007 Jan;5(1):58-61. doi: 10.1016/s1542-0124(12)70054-x.

Persistent depot of triamcinolone acetonide after a single intravitreal injection.

Indian J Ophthalmol. 2005 Mar;53(1):65-6. doi: 10.4103/0301-4738.15291.

Triamcinolone acetonide in ocular therapeutics.

Surv Ophthalmol. 2007 Sep-Oct;52(5):503-22. doi: 10.1016/j.survophthal.2007.06.004.

Intravitreal triamcinolone acetonide in Eales disease.

Retina. 2006 Feb;26(2):227-9. doi: 10.1097/00006982-200602000-00020.

Effects of triamcinolone acetonide injections with and without preservative.

Br J Ophthalmol. 2007 Sep;91(9):1099-101. doi: 10.1136/bjo.2007.117432.

Transscleral diffusion of triamcinolone.

Ophthalmology. 2011 Jul;118(7):1487; author reply 1487-1487.e1. doi: 10.1016/j.ophtha.2011.02.007.

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Br J Ophthalmol. 2004 Apr;88(4):598; author reply 598.

Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.

Indian J Ophthalmol. 2006 Dec;54(4):290; author reply 290-1. doi: 10.4103/0301-4738.27969.

Intravitreal use of triamcinolone acetonide: an experimental clinical procedure.

Acta Ophthalmol Scand. 2005 Oct;83(5):526-7. doi: 10.1111/j.1600-0420.2005.00538.x.

Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.

Am J Ophthalmol. 2005 Nov;140(5):958; author reply 958-9. doi: 10.1016/j.ajo.2005.05.053.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacotherapy: how much drug is there?

Ocul Surf. 2007 Jan;5(1):58-61. doi: 10.1016/s1542-0124(12)70054-x.

Persistent depot of triamcinolone acetonide after a single intravitreal injection.

Indian J Ophthalmol. 2005 Mar;53(1):65-6. doi: 10.4103/0301-4738.15291.

Triamcinolone acetonide in ocular therapeutics.

Surv Ophthalmol. 2007 Sep-Oct;52(5):503-22. doi: 10.1016/j.survophthal.2007.06.004.

Intravitreal triamcinolone acetonide in Eales disease.

Retina. 2006 Feb;26(2):227-9. doi: 10.1097/00006982-200602000-00020.

Effects of triamcinolone acetonide injections with and without preservative.

Br J Ophthalmol. 2007 Sep;91(9):1099-101. doi: 10.1136/bjo.2007.117432.

Transscleral diffusion of triamcinolone.

Ophthalmology. 2011 Jul;118(7):1487; author reply 1487-1487.e1. doi: 10.1016/j.ophtha.2011.02.007.

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Br J Ophthalmol. 2004 Apr;88(4):598; author reply 598.

Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.

Indian J Ophthalmol. 2006 Dec;54(4):290; author reply 290-1. doi: 10.4103/0301-4738.27969.

Intravitreal use of triamcinolone acetonide: an experimental clinical procedure.

Acta Ophthalmol Scand. 2005 Oct;83(5):526-7. doi: 10.1111/j.1600-0420.2005.00538.x.

Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.

Am J Ophthalmol. 2005 Nov;140(5):958; author reply 958-9. doi: 10.1016/j.ajo.2005.05.053.